• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基异靛蓝及其溴代衍生物是选择性酪氨酸激酶抑制剂,可抑制细胞Stat3活性,并靶向胰腺导管腺癌中的CD133 +癌症干细胞。

Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC.

作者信息

Tegethoff Jana, Bischoff Roland, Saleh Sawsan, Blagojevic Biljana, Merz Karl-Heinz, Cheng Xinlai

机构信息

Department of Pharmacy and Molecular Biotechnology, Division of Pharmaceutical Biology, University of Heidelberg, Im Neuenheimer Feld 364, D-69120 Heidelberg, Germany.

Department of Chemistry, Division of Food Chemistry and Toxicology, University of Kaiserslautern, Erwin-Schrödinger-Strasse 52, D-67663 Kaiserslautern, Germany.

出版信息

Molecules. 2017 Sep 13;22(9):1546. doi: 10.3390/molecules22091546.

DOI:10.3390/molecules22091546
PMID:32961646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6151689/
Abstract

Indirubin is an active component of the herbal ingredient 'Danggui Longhui wan', which was used for the treatment of inflammation and chronic myeloid leukemia in China. The recent study showed its derivative methylisoindigo (also known as meisoindigo) preferentially targeting cancer stem cells (CSCs) in interference with AMPK and LKB1, the cellular metabolic sensors. In this study, we screened the effect of meisoindigo on a panel of 300 protein kinases and found that it selectively inhibited Stat3-associated tyrosine kinases and further confirmed its activity in cell based assays. To gain a deeper insight into the structure-activity relationship we produced 7 bromo-derivatives exhausting the accessible positions on the bisindole backbone except for in the 4-position due to the space limitation. We compared their anti-proliferative effects on tumor cells. We found that 6-bromomeisoindigo showed improved toxicity in company with increased Stat3 inhibition. Moreover, we detected that 6-bromomeisoindigo induced apoptosis of 95% of CD133+ pancreatic cancer cells. Considering that CD133 is a common marker highly expressed in a range of CSCs, our results imply the potential application of 6-bromomeisoindigo for the treatment of CSCs in different types of cancers.

摘要

靛玉红是中药成分“当归龙荟丸”的一种活性成分,在中国曾用于治疗炎症和慢性粒细胞白血病。最近的研究表明,其衍生物甲基异靛蓝(也称为美索靛蓝)优先靶向癌症干细胞(CSCs),干扰细胞代谢传感器AMPK和LKB1。在本研究中,我们筛选了美索靛蓝对一组300种蛋白激酶的作用,发现它选择性抑制与Stat3相关的酪氨酸激酶,并在细胞实验中进一步证实了其活性。为了更深入了解构效关系,由于空间限制,我们制备了7种溴代衍生物,穷尽了双吲哚骨架上除4位以外的可修饰位置。我们比较了它们对肿瘤细胞的抗增殖作用。我们发现6-溴美索靛蓝在增强对Stat3抑制作用的同时,毒性有所提高。此外,我们检测到6-溴美索靛蓝可诱导95%的CD133+胰腺癌细胞凋亡。鉴于CD133是在一系列癌症干细胞中高表达的常见标志物,我们的结果表明6-溴美索靛蓝在治疗不同类型癌症的癌症干细胞方面具有潜在应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/99465478b7b7/molecules-22-01546-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/9ef1e7a32715/molecules-22-01546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/2d776c62c8bb/molecules-22-01546-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/7723a6ce6e07/molecules-22-01546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/c2fa2d2f954c/molecules-22-01546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/f406b539e45f/molecules-22-01546-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/92c24083ba36/molecules-22-01546-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/99465478b7b7/molecules-22-01546-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/9ef1e7a32715/molecules-22-01546-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/2d776c62c8bb/molecules-22-01546-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/7723a6ce6e07/molecules-22-01546-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/c2fa2d2f954c/molecules-22-01546-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/f406b539e45f/molecules-22-01546-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/92c24083ba36/molecules-22-01546-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/383b/6151689/99465478b7b7/molecules-22-01546-g006.jpg

相似文献

1
Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC.甲基异靛蓝及其溴代衍生物是选择性酪氨酸激酶抑制剂,可抑制细胞Stat3活性,并靶向胰腺导管腺癌中的CD133 +癌症干细胞。
Molecules. 2017 Sep 13;22(9):1546. doi: 10.3390/molecules22091546.
2
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs.甲基异靛通过抑制 PDACs 中的 LKB1 和激活 AMPK 来干扰细胞代谢,从而优先杀死癌症干细胞。
Mol Oncol. 2016 Jun;10(6):806-24. doi: 10.1016/j.molonc.2016.01.008. Epub 2016 Feb 4.
3
The Role of Indirubins in Inflammation and Associated Tumorigenesis.靛玉红在炎症及相关肿瘤发生中的作用
Adv Exp Med Biol. 2016;929:269-290. doi: 10.1007/978-3-319-41342-6_12.
4
Anti-tumor activity of noble indirubin derivatives in human solid tumor models in vitro.新型靛玉红衍生物在人实体瘤体外模型中的抗肿瘤活性
Arch Pharm Res. 2009 Jun;32(6):915-22. doi: 10.1007/s12272-009-1614-2. Epub 2009 Jun 26.
5
Discovery of an Indirubin Derivative as a Novel c-Met Kinase Inhibitor with Anti-Tumor Effects.发现一种靛玉红衍生物作为具有抗肿瘤作用的新型c-Met激酶抑制剂。
Biomol Ther (Seoul). 2019 Mar 1;27(2):216-221. doi: 10.4062/biomolther.2018.091.
6
Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China.靛玉红和异靛蓝在中国治疗慢性粒细胞白血病中的应用。
Leuk Lymphoma. 2002 Sep;43(9):1763-8. doi: 10.1080/1042819021000006295.
7
Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.吲哚并咔唑类化合物在药物化学中的抗癌潜力:生物活性、结构修饰和构效关系。
Eur J Med Chem. 2021 Nov 5;223:113652. doi: 10.1016/j.ejmech.2021.113652. Epub 2021 Jun 17.
8
2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.从虎杖中提取的新型小分子 STAT3 信号抑制剂 2-乙氧基紫檀烷酮,能够抑制肝癌细胞和 HCC 肿瘤干细胞的生长并诱导其凋亡。
BMC Complement Altern Med. 2019 Feb 1;19(1):38. doi: 10.1186/s12906-019-2440-9.
9
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.用于对抗增殖性疾病的靛玉红及靛玉红衍生物
Evid Based Complement Alternat Med. 2015;2015:654098. doi: 10.1155/2015/654098. Epub 2015 Sep 17.
10
Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.新型靛玉红衍生物作为具有CDK2抑制活性的有效抗增殖剂的合成及其构效关系
Bioorg Med Chem. 2006 Jan 1;14(1):237-46. doi: 10.1016/j.bmc.2005.08.008. Epub 2005 Sep 22.

引用本文的文献

1
Advances in the Search for SARS-CoV-2 M and PL Inhibitors.新型冠状病毒M和PL抑制剂的研究进展
Pathogens. 2024 Sep 24;13(10):825. doi: 10.3390/pathogens13100825.
2
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review.天然 STAT3 抑制剂在癌症治疗中的应用:全面文献综述。
Recent Pat Anticancer Drug Discov. 2024;19(4):403-502. doi: 10.2174/1574892818666230803100554.
3
Special Issue: Kinase inhibitors.特刊:激酶抑制剂

本文引用的文献

1
Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.通过对母体天然分子的结构修饰,鉴定出水溶性靛玉红衍生物作为胰岛素样生长因子 1 受体的有效抑制剂。
J Med Chem. 2017 Jun 22;60(12):4949-4962. doi: 10.1021/acs.jmedchem.7b00324. Epub 2017 Jun 6.
2
Reprogramming of Cancer Metabolism by MYC.MYC对癌症代谢的重编程
Front Cell Dev Biol. 2017 Apr 11;5:35. doi: 10.3389/fcell.2017.00035. eCollection 2017.
3
The Role of Indirubins in Inflammation and Associated Tumorigenesis.
Molecules. 2018 Jul 22;23(7):1818. doi: 10.3390/molecules23071818.
靛玉红在炎症及相关肿瘤发生中的作用
Adv Exp Med Biol. 2016;929:269-290. doi: 10.1007/978-3-319-41342-6_12.
4
STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.信号转导和转录激活因子3作为醛脱氢酶阳性及CD44+/CD24+干细胞样胰腺癌细胞中的潜在治疗靶点。
Int J Oncol. 2016 Dec;49(6):2265-2274. doi: 10.3892/ijo.2016.3728. Epub 2016 Oct 12.
5
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs.甲基异靛通过抑制 PDACs 中的 LKB1 和激活 AMPK 来干扰细胞代谢,从而优先杀死癌症干细胞。
Mol Oncol. 2016 Jun;10(6):806-24. doi: 10.1016/j.molonc.2016.01.008. Epub 2016 Feb 4.
6
Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.在乳腺癌中,TrkB通过激活IL6/JAK2/STAT3和PI3K/AKT信号通路诱导转移潜能。
Oncotarget. 2015 Nov 24;6(37):40158-71. doi: 10.18632/oncotarget.5522.
7
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.用于对抗增殖性疾病的靛玉红及靛玉红衍生物
Evid Based Complement Alternat Med. 2015;2015:654098. doi: 10.1155/2015/654098. Epub 2015 Sep 17.
8
Ethyl 2-((4-Chlorophenyl)amino)thiazole-4-carboxylate and Derivatives Are Potent Inducers of Oct3/4.乙酯 2-((4-氯苯基)氨基)噻唑-4-羧酸及其衍生物是 Oct3/4 的有效诱导物。
J Med Chem. 2015 Aug 13;58(15):5742-50. doi: 10.1021/acs.jmedchem.5b00226. Epub 2015 Jul 23.
9
Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 Inducers.鉴定2-[4-[(4-甲氧基苯基)甲氧基]苯基]乙腈及其衍生物为强效Oct3/4诱导剂。
J Med Chem. 2015 Jun 25;58(12):4976-83. doi: 10.1021/acs.jmedchem.5b00144. Epub 2015 May 7.
10
Revisiting STAT3 signalling in cancer: new and unexpected biological functions.重新审视 STAT3 信号通路在癌症中的作用:新的、意想不到的生物学功能。
Nat Rev Cancer. 2014 Nov;14(11):736-46. doi: 10.1038/nrc3818.